S. Koreas biotech sector kicks off 2025 with multi-billion-dollar deals K-Bio firms secure nearly $2.3 billion in licensing deals in Q1 ...

Investing.com -- Eli Lilly (NYSE:LLY) has filed for a six-part note offering, with the aggregate principal amount of the notes... - OliX to Develop OLX75016 for MASH and Other Cardiometabolic ...

Another big pharma in the RNA business is Eli Lilly, which has been spending quite the penny on partnerships lately. Its collaboration with South Korean biotech OliX is to develop and commercialize ...

Eli Lilly has linked lepodisiran to sustained reductions in a cardiovascular disease risk factor for nearly 1.5 years, bolstering the company’s argument that the siRNA candidate has an edge over ...

John Benjamin Hickey and Thomas Sadoski co-star. As the official synopsis teases, Lilly “discovers that the system has been cheating her, paying her close to half of what the men with the same ...

The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will prevent heart attacks and strokes. By Gina Kolata As many as one in five ...

In honor of Equal Pay Day, PEOPLE has the exclusive first trailer for 'Lilly,' starring Patricia Clarkson Sharareh Drury is a writer on the Movies team at PEOPLE. She joined PEOPLE in 2025 and has ...

Georgia football has hired both Phil Rauscher and John Lilly to the coaching staff. On Monday, it was announced that Georgia was targeting two NFL coaches and on Tuesday, it was made official that ...

European Medicines Agency advisers said Friday that Eli Lilly’s Alzheimer’s disease treatment should not be approved, once again diverging from their U.S. counterparts. The Committee for ...

Eli Lilly (LLY) ended the recent trading session at $912.76, demonstrating a -1.82% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 1.78%.